Warning: The NCBI web site requires JavaScript to function. more...
Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS.
Retrovirology. 2008 Dec 11;5:112.
Related citations
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
Rodés B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM, Jimenez V, Wrin T, Bassani S, Soriano V.
AIDS. 2004 May 21;18(8):1109-16.
Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E, Ashton LJ, Smith DG, Ziegler JB, Kaldor JM, Cooper DA, Stewart GJ, Ffrench RA.
J Med Virol. 2003 Dec;71(4):483-91.
A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection.
Imami N, Pires A, Hardy G, Wilson J, Gazzard B, Gotch F.
J Virol. 2002 Sep;76(18):9011-23.
Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.
Feeney ME, Draenert R, Roosevelt KA, Pelton SI, McIntosh K, Burchett SK, Mao C, Walker BD, Goulder PJ.
J Immunol. 2003 Dec 15;171(12):6968-75.
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
Boaz MJ, Waters A, Murad S, Easterbrook PJ, D'Sousa E, van Wheeley C, Vyakarnam A.
Clin Exp Immunol. 2003 Dec;134(3):454-63.
An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
Birch MR, Learmont JC, Dyer WB, Deacon NJ, Zaunders JJ, Saksena N, Cunningham AL, Mills J, Sullivan JS.
J Clin Virol. 2001 Oct;22(3):263-70.
Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
Boaz MJ, Waters A, Murad S, Easterbrook PJ, Vyakarnam A.
J Immunol. 2002 Dec 1;169(11):6376-85.
Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.
Dyer WB, Geczy AF, Kent SJ, McIntyre LB, Blasdall SA, Learmont JC, Sullivan JS.
AIDS. 1997 Nov;11(13):1565-74.
HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.
Koeppe JR, Campbell TB, Rapaport EL, Wilson CC.
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):140-8.
HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
Bernard NF, Pederson K, Chung F, Ouellet L, Wainberg MA, Tsoukas CM.
AIDS. 1998 Nov 12;12(16):2125-39.
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD.
J Immunol. 1996 Apr 1;156(7):2616-23.
HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P, van Bockel DJ, Petoumenos K, McMurchie M, Finlayson R, Middleton MG, Davenport MP, Venturi V, Suzuki K, Gelgor L, Kaldor JM, Cooper DA, Kelleher AD.
J Immunol. 2011 Jan 1;186(1):479-88. Epub 2010 Nov 29.
Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets.
Dyer WB, Kuipers H, Coolen MW, Geczy AF, Forrester J, Workman C, Sullivan JS.
AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):999-1010.
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.
AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28.
Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function.
Palmer BE, Boritz E, Wilson CC.
J Immunol. 2004 Mar 1;172(5):3337-47.
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, Roudot-Thoraval F.
Blood. 1997 Aug 1;90(3):1133-40.
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
Hay CM, Ruhl DJ, Basgoz NO, Wilson CC, Billingsley JM, DePasquale MP, D'Aquila RT, Wolinsky SM, Crawford JM, Montefiori DC, Walker BD.
J Virol. 1999 Jul;73(7):5509-19.
Progression of HIV to AIDS: a protective role for HLA-B27?
den Uyl D, van der Horst-Bruinsma IE, van Agtmael M.
AIDS Rev. 2004 Apr-Jun;6(2):89-96. Review.
Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status.
Jiao Y, Xie J, Li T, Han Y, Qiu Z, Zuo L, Wang A.
J Acquir Immune Defic Syndr. 2006 Jul;42(3):263-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on